UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

Cancer cell, 2006-07, Vol.10 (1), p.25-38

2006

Volltextzugriff (PDF)

DNA Repair and Survival in Lung Cancer — The Two Faces of Janus

The New England journal of medicine, 2007-02, Vol.356 (8), p.771-773

Gazdar, Adi F

2007

Volltextzugriff (PDF)

A Translational View of the Molecular Pathogenesis of Lung Cancer

Journal of thoracic oncology, 2007-04, Vol.2 (4), p.327-343

2007

Volltextzugriff (PDF)

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity

Nature cancer, 2020-04, Vol.1 (4), p.437-451

2020

Volltextzugriff (PDF)

Lung cancer preneoplasia

Annual review of pathology, 2006-01, Vol.1 (1), p.331-348

2006

Volltextzugriff (PDF)

Personalized Medicine and Inhibition of EGFR Signaling in Lung Cancer

The New England journal of medicine, 2009-09, Vol.361 (10), p.1018-1020

Gazdar, Adi F

2009

Volltextzugriff (PDF)

Knockdown of ZEB1 , a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells

Cancer letters, 2010-10, Vol.296 (2), p.216-224

2010

Volltextzugriff (PDF)

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.1642-1646

2005

Volltextzugriff (PDF)

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy

Molecular cancer therapeutics, 2011-02, Vol.10 (2), p.336-346

2011

Volltextzugriff (PDF)

Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors

Cell reports (Cambridge), 2017-05, Vol.19 (8), p.1669-1684

2017

Volltextzugriff (PDF)

Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non―Small Cell Lung Cancer Harboring K-RAS Mutations

Cancer research (Chicago, Ill.), 2009-10, Vol.69 (19), p.7644-7652

2009

Volltextzugriff (PDF)

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

PloS one, 2009-02, Vol.4 (2), p.e4576-e4576

2009

Volltextzugriff (PDF)

Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

PloS one, 2012-03, Vol.7 (3), p.e33003-e33003

2012

Volltextzugriff (PDF)

The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers

Clinical cancer research, 2005-02, Vol.11 (3), p.1167-1173

2005

Volltextzugriff (PDF)

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer

International journal of cancer, 2012-04, Vol.130 (8), p.1733-1744

2012

Volltextzugriff (PDF)

Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling

Cancer research (Chicago, Ill.), 2015-02, Vol.75 (4), p.666-675

2015

Volltextzugriff (PDF)

Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non–Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic Features

Clinical cancer research, 2006-03, Vol.12 (5), p.1647-1653

2006

Volltextzugriff (PDF)

Genomic alterations in cultured human embryonic stem cells

Nature genetics, 2005-10, Vol.37 (10), p.1099-1103

2005

Volltextzugriff (PDF)

Erratum: Small-cell lung cancer: what we know, what we need to know and the path forward

Nature reviews. Cancer, 2017-12, Vol.17 (12), p.765-765

2017

Volltextzugriff (PDF)

Lung cancer in never smokers - a different disease

Nature reviews. Cancer, 2007-10, Vol.7 (10), p.778-790

2007

Volltextzugriff (PDF)

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (2), p.944-950

2006

Volltextzugriff (PDF)

Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis

International journal of molecular sciences, 2022-12, Vol.24 (1), p.584

2022

Volltextzugriff (PDF)

The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma

International journal of cancer, 2012-12, Vol.131 (12), p.2820-2831

2012

Volltextzugriff (PDF)

Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers?

Trends in molecular medicine, 2004-10, Vol.10 (10), p.481-486

2004

Volltextzugriff (PDF)

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

Cancer cell, 2006-07, Vol.10 (1), p.39-50

2006

Volltextzugriff (PDF)

26 – 50 von 710

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(667)
Mit Volltextzugriff
(658)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(490)
Science & Technology
(481)
Life Sciences & Biomedicine
(453)
Oncology
(344)
Biological And Medical Sciences
(279)
Medical Sciences
(255)
Lung Neoplasms - Genetics
(200)
Tumors
(181)
Female
(180)
Lung Neoplasms - Pathology
(144)
Male
(134)
Lung Cancer
(133)
Pneumology
(130)
Tumors Of The Respiratory System And Mediastinum
(128)
Carcinoma, Non-Small-Cell Lung - Genetics
(115)
Middle Aged
(110)
Tumor Cells, Cultured
(108)
Aged
(99)
Animals
(97)
Mutation
(95)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

DNA Repair and Survival in Lung Cancer — The Two Faces of Janus

A Translational View of the Molecular Pathogenesis of Lung Cancer

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity

Lung cancer preneoplasia

Personalized Medicine and Inhibition of EGFR Signaling in Lung Cancer

Knockdown of ZEB1 , a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy

Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors

Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non―Small Cell Lung Cancer Harboring K-RAS Mutations

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer

Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling

Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non–Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic Features

Genomic alterations in cultured human embryonic stem cells

Erratum: Small-cell lung cancer: what we know, what we need to know and the path forward

Lung cancer in never smokers - a different disease

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines

Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis

The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma

Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers?

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

Suchergebnisse filtern